Enterprise Learning Strategy and Operational Launch Support
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA) intends to issue a sole source, firm-fixed-price order to GOVALLIES LLC for Enterprise Learning Strategy and Operational Launch Support. This effort will assist the FDA's Office of Human Capital Management (OHCM) in transitioning to a coordinated enterprise learning model. This notice is for informational purposes only and is not a request for competitive proposals.
Scope of Work
The selected contractor will provide assistance to OHCM to evaluate current learning programs and develop structured frameworks, governance models, and operational processes necessary to support enterprise learning management. This transition aims to move FDA from independently managed learning activities across various Centers, Offices, and Programs (COPs) to a more coordinated enterprise learning model, improving efficiency, reducing duplication, and ensuring alignment with federal workforce policies and Agency priorities.
Contract & Timeline
- Type: Sole Source, Firm-Fixed-Price Order
- Duration: 1-year base period
- NAICS: 541611 - Administrative Management and General Management Consulting Services
- PSC: U009 - Education Services
- Set-Aside: None (Sole Source under FAR 6.103-1)
- Response Date: July 2, 2026 (for inquiries, not proposals)
- Published: June 17, 2026
Additional Notes
This presolicitation notice explicitly states that it is not a request for competitive proposals. The FDA intends to award this contract to GOVALLIES LLC based on a sole source justification in accordance with FAR 6.103-1.